Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
about
Early detection of diabetic kidney disease: Present limitations and future perspectivesA Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational ModificationsMetabolomics and Type 2 Diabetes: Translating Basic Research into Clinical ApplicationLoss of Renal Tubular PGC-1α Exacerbates Diet-Induced Renal Steatosis and Age-Related Urinary Sodium Excretion in MiceMetabolomics and diabetes: analytical and computational approachesThe organic anion transporter (OAT) family: a systems biology perspectiveObesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox BalanceMitochondrial hormesis and diabetic complicationsSystems biology analysis reveals role of MDM2 in diabetic nephropathyAlterations of urinary metabolite profile in model diabetic nephropathy.Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.The metabolic profile of a rat model of chronic kidney disease.PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells.Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches.Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty ratsEnvironmental exposure and mitochondrial epigenetics: study design and analytical challengesMetabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertensionMetabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry.Antidiabetic and renoprotective effects of Cladophora glomerata Kützing extract in experimental type 2 diabetic rats: a potential nutraceutical product for diabetic nephropathy.A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.Metabolomics and renal disease.Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible MediatorHigh-Resolution Metabolomics: Review of the Field and Implications for Nursing Science and the Study of Preterm BirthMetabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney DiseaseFarnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.What do drug transporters really do?Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and DiabetesIdentification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profilingMetabolomics in diabetic complications.AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial functionTissue-specific metabolic reprogramming drives nutrient flux in diabetic complicationsPlasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profilesHigh glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?PGC1α Activators Mitigate Diabetic Tubulopathy by Improving Mitochondrial Dynamics and Quality Control.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.
P2860
Q26741494-F416BCBF-E118-4117-A13E-C49B22F8CC0BQ26769678-72AD5F01-3F19-45F8-9EFB-BC79D5B2063CQ26774386-9F535844-11AE-46A4-BA70-8B77E91F8650Q27335107-FDC62D19-05C7-428B-83F6-A39500A09315Q28084835-E08B8CC4-2F53-4C14-9934-ABA2015F9BA3Q28085671-9EBEF3F0-57C4-4A94-A132-88738D51718AQ28385322-E65BC8EE-E510-4A71-A978-8FE812F3BB34Q28388387-1074A318-12C9-465C-A114-CE3D081F69AAQ28821589-AC18F5C5-06C6-4111-8DD8-C98FF5E5ECEFQ30369623-FEA9692C-CBCF-4769-95B6-D2CB31E2A652Q31143152-9A04CB7B-32BB-4A9E-998E-30D0D3D24044Q33727136-5ACF705C-311E-4138-9E28-835688142A27Q33849235-C1F9E8F1-405F-4D7F-B525-8C46ECAA28CFQ34318248-E35854B2-98B9-4430-9232-A802392C56F8Q34411671-F3AD32DE-1DCA-4D13-8C24-037116CEC3A2Q35077449-17089271-9B0C-4CB8-B5FF-F092C7DC7D88Q35153934-F4A3CB87-E99C-4FFF-9749-985EFCCC1A26Q35161725-DCFF6939-BDB0-4A1A-BDAD-ECD3C7496AA8Q35180301-AAA73D3F-6413-48DF-AC2F-EBDF72E0DCADQ35345065-72F3FF0B-7211-4A07-8284-150DE3ABB435Q35606905-C18F4F95-51D4-4941-B095-7C85D98DF669Q35658612-824A2C55-097C-4BB0-9A0B-E9E4C2053EE9Q35778649-4DD9E331-55C4-487D-9F1C-A22207C69F85Q35947731-A0CE719B-AA43-4E21-8C3D-99928EB84748Q36056764-9107501F-BB9E-4970-8F77-B68FBF431E1FQ36387102-160AF1E7-4459-4427-BD2C-28A11E0983BDQ36514979-E813DF3E-155F-4EB9-A3D5-B3BE204E8242Q36518342-210033D6-7BBF-47D8-9B9C-5BA7AFDFCF5DQ36571217-8F99C076-506A-4FB5-9588-7C3F590DB9DCQ36638243-891C58B1-81EF-4362-AAD0-6E04787FCEF5Q36849190-9391CB6C-3354-44A1-95DE-FD7D7A0DF25BQ36910790-C99B5714-15E2-46F8-9188-57081C89653EQ37041169-BC32A14C-2131-4B98-B8BC-6C1FCE3B9577Q37259208-4709E094-260E-45A2-BE22-E36F5380EE6AQ37277053-48DE73E6-BB35-4DF5-910B-4A787D938A8DQ37358885-6A524AF6-B2EF-4141-A36B-B41399577899Q37510406-F61940F3-DC49-405F-9ED3-F33E9AA2BF55Q37686261-DC9417EC-EF28-45EA-AB6C-E4932CF652B9Q37734334-09470E9D-115E-43A0-8F94-FEE411B39424Q38198872-1A00F454-7AE8-43EB-8064-9635C9979D95
P2860
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
@en
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
@nl
type
label
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
@en
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
@nl
prefLabel
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
@en
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
@nl
P2093
P2860
P50
P356
P1476
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
@en
P2093
Bethany Karl
Bruce A Barshop
Christina L Wassel
Clemens D Cohen
Jon A Gangoiti
Kumar Sharma
Loki Natarajan
Maggie Diamond-Stanic
Maja T Lindenmeyer
P2860
P304
P356
10.1681/ASN.2013020126
P577
2013-10-10T00:00:00Z